At the 60th international festival of popular science films, Academia Film Olomouc, researchers from the National Institute for Cancer Research (NICR) will also be among the invited speakers. Come and listen to them!
Date: Wednesday, April 23 at 4:00 PM
Venue: Regional Museum Olomouc
For visitors of Academia Film Olomouc (AFO), NICR scientists have prepared a follow-up discussion after the screening of the historical film “Before It’s Too Late”, taking place on Wednesday, April 23 at 4:00 PM at the Regional Museum in Olomouc. The discussion will explore how our understanding of cancer and its treatment has evolved over the 70 years since the film was made. The audience will hear not only about what modern precision oncology can do—enabling treatment to be tailored to each patient based on their specific tumor—but also about what researchers are currently investigating for the future.
Participants in the discussion will include Marián Hajdúch, Medical Director of NICR and Director of the Institute of Molecular and Translational Medicine at the Faculty of Medicine, Palacký University and University Hospital Olomouc; Jaroslav Štěrba, Scientific Director of NÚVR and Head of the Department of Pediatric Oncology at the Faculty of Medicine, Masaryk University and University Hospital Brno; Ondřej Slabý, Head of the Center for Precision Medicine at University Hospital Brno, whose research group Translational Cancer Genomics is part of NÚVR; and Tomáš Kazda, Head of the Brain and Spinal Tumor Center at the Masaryk Memorial Cancer Institute, one of NÚVR’s partners.
Two days later, on Friday, April 25 between 4:00 and 6:00 PM, the competition film Burkitt will be screened at Metropol Cinema. This visually unconventional film connects the topic of medical research by Irish surgeon Denis Burkitt, who identified a malignant disease in the population of Ugandan children that now bears his name, with racial issues, wartime events, and a meditation on the meaning of life. On the occasion of the competition screening, there will be a meeting with the filmmakers, also attended by Pavel Klener as an invited expert. He is the head of the Prague Lymphoma Lab research group at the Institute of Pathological Physiology, First Faculty of Medicine, Charles University, which is part of NICR.
